Mylan sues Celgene over cancer drugs

Generic drug maker Mylan Pharmaceuticals Inc. on Thursday sued Celgene Corp. in federal court in New Jersey, claiming the company had monopolized sales of two prescription medications by keeping lower-priced generics out of the market...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.